Target intelligence / Profile preview

Bacterial 30S ribosomal subunit (16S rRNA A-site and ribosomal protein S12) (30S A-site/S12)

Target
30S A-site/S12
Molecular classification
Ribonucleoprotein complex, Other
01

Overview

The bacterial 30S ribosomal subunit, specifically the 16S rRNA A-site and its associated protein S12, constitutes the essential decoding center of the bacterial translation machinery (Carter et al., 2000, Nature). This complex is responsible for the accurate selection of aminoacyl-tRNA molecules based on the mRNA codon sequence, a process vital for protein synthesis (Ogle et al., 2001, Science). Ribosomal protein S12 (rpsL) is crucial for maintaining the fidelity of this process, as it stabilizes the "closed" conformation of the 30S subunit during cognate tRNA recognition (UniProt P0A7M2). This site is the primary target for aminoglycoside antibiotics, such as streptomycin and gentamicin, which bind to the A-site and induce conformational changes that lead to mRNA misreading and the production of aberrant proteins (StatPearls, 2023). These disruptions are bactericidal, making the 30S A-site/S12 complex a critical target for treating severe infections caused by Gram-negative bacteria and Mycobacterium tuberculosis (PubMed: 11557144). Resistance often arises through mutations in the rpsL gene or the 16S rRNA, which decrease drug affinity while potentially altering translational speed and accuracy (PubMed: 10760218).

Other names
Decoding center16S rRNA A-siterpsL-16S rRNA complexAminoacyl-tRNA binding site30S decoding site
02

Mechanism of action

Inhibition of protein synthesis through the induction of mRNA misreading and the stabilization of the aminoacyl-tRNA in the A-site, which prevents effective translocation.

03

Biological functions

Protein biosynthesismRNA decodingTranslational proofreadingOther
04

Disease associations

Infection
05

Safety considerations

OtotoxicityNephrotoxicityNeuromuscular blockadeSelection for antibiotic resistance
06

Interacting drugs

Streptomycin

7 more in the full profile.

07

Biomarkers

rpsL gene mutation16S rRNA gene mutationMinimum inhibitory concentration (MIC)Aminoglycoside serum concentration

Beyond the preview

Go deeper on Bacterial 30S ribosomal subunit (16S rRNA A-site and ribosomal protein S12) (30S A-site/S12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 30S ribosomal subunit (16S rRNA A-site and ribosomal protein S12) (30S A-site/S12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call